Home
Solara Active Pharma Sciences Ltd PE Ratio

Solara Active Pharma Sciences Ltd
NSE: SOLARA
PE
Key Highlights
- The P/E Ratio of Solara Active Pharma Sciences Ltd is 0 as of 28 Apr 15:30 PM .
- The P/E Ratio of Solara Active Pharma Sciences Ltd changed from 10.4 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
- The Latest Trading Price of Solara Active Pharma Sciences Ltd is ₹ 517 as of 28 Apr 16:01 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 39.9 in 5 years. This represents a CAGR of 13.70%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 39.9. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Solara Active Pharma Sciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Solara Active Pharma Sciences Ltd
Company Fundamentals for Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences Ltd
NSE: SOLARA
Share Price
Market Price of Solara Active Pharma Sciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
25 Apr 2025 | 509.4 |
24 Apr 2025 | 533.95 |
23 Apr 2025 | 518.4 |
22 Apr 2025 | 522.75 |
21 Apr 2025 | 521.15 |
17 Apr 2025 | 522.85 |
16 Apr 2025 | 519.05 |
15 Apr 2025 | 518.15 |
11 Apr 2025 | 510.1 |
09 Apr 2025 | 489.65 |
SWOT Analysis Of Solara Active Pharma Sciences Ltd
BlinkX Score for Solara Active Pharma Sciences Ltd
Asset Value vs Market Value of Solara Active Pharma Sciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Solara Active Pharma Sciences Ltd | 1836 | - |
Sun Pharmaceutical Industries Ltd | 428725 | 36.3 |
Divis Laboratories Ltd | 159525 | 77.2 |
Cipla Ltd | 123202 | 24.7 |
Torrent Pharmaceuticals Ltd | 109514 | 58.8 |
Mankind Pharma Ltd | 105276 | 51.6 |
Company | |
---|---|
Solara Active Pharma Sciences Ltd | 1836 |
Sun Pharmaceutical Industries Ltd | 428725 |
Divis Laboratories Ltd | 159525 |
Cipla Ltd | 123202 |
Torrent Pharmaceuticals Ltd | 109514 |
Mankind Pharma Ltd | 105276 |
PE Ratio of Solara Active Pharma Sciences Ltd Explained
₹1836
Market cap
₹-252
Earnings
0.0X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Solara Active Pharma Sciences Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Solara Active Pharma Sciences Ltd
Historical Revenue, EBITDA and Net Profit of Solara Active Pharma Sciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Solara Active Pharma Sciences Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Solara Active Pharma Sciences Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Solara Active Pharma Sciences Ltd
About Solara Active Pharma Sciences Ltd
- Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs).
- The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets.
- The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others.
- It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches.
Solara Active Pharma Sciences Ltd News Hub
Solara Active Pharma Sciences schedules AGM
Solara Active Pharma Sciences announced that the Annual General Meeting (AGM) of the company will be
Read more
30 Aug 24
Solara Active Pharma Sciences to incorporate wholly owned subsidiary
Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in relation to p
Read more
07 Feb 25
Solara Active Pharma Sciences reports consolidated net profit of Rs 8.01 crore in the September 2024 quarter
Net profit of Solara Active Pharma Sciences reported to Rs 8.01 crore in the quarter ended September
Read more
21 Oct 24
Solara Active Pharma Sciences allots 49,000 equity shares under ESOP
Solara Active Pharma Sciences has allotted 49,000 equity shares under ESOP on 21 October 2024. Power
Read more
21 Oct 24